ResMed Stock Analysis

RMD -  USA Stock  

USD 267.38  5.81  2.13%

The latest price surge of ResMed Inc created some momentum for shareholders as it was traded today as low as 263.31 and as high as 272.88 per share. The company directors and management may have good odds in positioning the company resources to exploit market volatility in September. The stock standard deviation of daily returns for 90 days investing horizon is currently 1.29. The below-average Stock volatility is a good sign for longer-term investment options and for buy-and-hold investors.
Additionally, take a look at Your Equity Center.

Search Stock Analysis 

The ResMed stock analysis report makes it easy to digest most publicly released information about ResMed and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. ResMed Stock analysis module also helps to analyze the ResMed price relationship with some important fundamental indicators such as market cap and management efficiency.

ResMed Stock Analysis Notes

About 70.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.69. ResMed Inc next dividend is scheduled to be issued on the 12th of May 2021. The entity had 2:1 split on the 31st of August 2010. ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. ResMed operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 7770 people. To find out more about ResMed Inc contact Michael Farrell at 858 836-5000 or learn more at

ResMed Inc Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. ResMed's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding ResMed Inc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
ResMed Inc is unlikely to experience financial distress in the next 2 years
ResMed Inc has a poor financial position based on the latest SEC disclosures
About 70.0% of the company shares are owned by institutional investors
Latest headline from Medical Products Aug 5 Earnings Roster BDX, RMD More - Nasdaq

ResMed Inc Upcoming and Recent Events

Earnings reports are used by ResMed to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to ResMed previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report5th of August 2021
Next Earnings Report4th of November 2021
Next Fiscal Quarter End30th of June 2021
Next Fiscal Year End5th of August 2021
Last Quarter Report31st of March 2021
Last Earning Announcement30th of June 2020

ResMed Largest EPS Surprises

Earnings surprises can significantly impact ResMed's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

ResMed Thematic Classifications

In addition to having ResMed stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Obamacare Repeal IdeaObamacare Repeal
Large healthcare related equities associated with Obamacare

ResMed Market Capitalization

The company currently falls under 'Large-Cap' category with total capitalization of 39.74 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ResMed's market, we take the total number of its shares issued and multiply it by ResMed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

ResMed Profitablity

ResMed's profitability indicators refer to fundamental financial ratios that showcase ResMed's ability to generate income relative to its revenue or operating costs. If, let's say, ResMed is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, ResMed's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of ResMed's profitability requires more research than a typical breakdown of ResMed's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of 14.79 %, which may imply that it executes well on its competitive polices and has reasonable control over its expenses and variable costs. This is very large. In the same way, it shows Net Operating Margin of 33.01 %, which entails that for every 100 dollars of revenue, it generated 0.33 of operating income.
Last ReportedProjected for 2021
Return on Investment 20.77  18.83 
Return on Average Assets 16.44  16.01 
Return on Average Equity 24.49  20.91 
Return on Invested Capital 0.29  0.28 
Return on Sales 0.22  0.22 

Management Efficiency

The entity has Return on Asset of 12.4 % which means that on every $100 spent on asset, it made $12.4 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 18.42 %, implying that it generated $18.42 on every 100 dollars invested. ResMed management efficiency ratios could be used to measure how well resmed inc manages its routine affairs as well as how well it operates its assets and liabilities. As of August 5, 2021, Return on Investment is expected to decline to 18.83. In addition to that, Return on Average Assets is expected to decline to 16.01. ResMed Goodwill and Intangible Assets are projected to increase significantly based on the last few years of reporting. The past year's Goodwill and Intangible Assets were at 1.22 Billion. The current year Net Current Assets as percentage of Total Assets is expected to grow to 33.57, whereas Current Assets are forecasted to decline to about 1.3 B.
Last ReportedProjected for 2021
Book Value per Share 10.85  8.71 
Enterprise Value over EBIT 21.85  22.43 
Enterprise Value over EBITDA 18.39  18.60 
Price to Book Value 6.02  5.91 
Tangible Assets Book Value per Share 12.15  9.79 
Enterprise Value7.7 B8.3 B
Tangible Asset Value1.7 B1.4 B

Technical Drivers

As of the 5th of August, ResMed holds the Downside Deviation of 0.9035, standard deviation of 1.21, and Risk Adjusted Performance of 0.3229. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of ResMed, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We have collected data for eighteen technical drivers for ResMed Inc, which can be compared to its competitors. Please check ResMed Inc jensen alpha, potential upside, as well as the relationship between the Potential Upside and skewness to decide if ResMed Inc is priced some-what accurately, providing market reflects its current price of 267.38 per share. Given that ResMed has treynor ratio of 2.04, we recommend you to check out ResMed Inc's recent market performance to make sure the company can sustain itself at a future point.

ResMed Inc Price Movement Analysis

The output start index for this execution was twenty-eight with a total number of output elements of thirty-three. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. ResMed middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for ResMed Inc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.

ResMed Inc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ResMed insiders, such as employees or executives, is commonly permitted as long as it does not rely on ResMed's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ResMed insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

ResMed Predictive Daily Indicators

ResMed intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of ResMed stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

ResMed Forecast Models

ResMed time-series forecasting models is one of many ResMed's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ResMed's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About ResMed Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how ResMed stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ResMed shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as ResMed. By using and applying ResMed Stock analysis, traders can create a robust methodology for identifying ResMed entry and exit points for their positions.
Last ReportedProjected for 2021
Operating Margin 24.64  22.75 
EBITDA Margin 28.70  25.63 
Gross Margin 66.81  69.74 
Profit Margin 24.18  23.44 
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. ResMed operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 7770 people.

Current ResMed Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. ResMed analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. ResMed analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
ResMed Inc current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most ResMed analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand ResMed stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of ResMed Inc, talking to its executives and customers, or listening to ResMed conference calls.
ResMed Analyst Advice Details

ResMed Stock Analysis Indicators

ResMed Inc stock analysis indicators help investors evaluate how ResMed stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading ResMed shares will generate the highest return on investment. By understating and applying ResMed stock analysis, traders can identify ResMed position entry and exit signals to maximize returns.
Quick Ratio0.90
Trailing Annual Dividend Rate1.56
Fifty Two Week Low165.72
Revenue Growth-0.10%
Payout Ratio49.84%
Average Daily Volume Last 10 Day403.42k
Shares Short Prior Month1.11M
Average Daily Volume In Three Month604.63k
Shares Percent Shares Out0.98%
Gross Margins59.82%
Forward Price Earnings48.51
Short Percent Of Float1.10%
Float Shares143.1M
Fifty Two Week High273.17
Fifty Day Average249.91
Enterprise Value To Ebitda35.31
Two Hundred Day Average212.46
Enterprise Value To Revenue11.66
Trailing Annual Dividend Yield0.58%
Additionally, take a look at Your Equity Center. Note that the ResMed Inc information on this page should be used as a complementary analysis to other ResMed's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Piotroski F Score module to get Piotroski F Score based on binary analysis strategy of nine different fundamentals.

Complementary Tools for ResMed Stock analysis

When running ResMed Inc price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Money Managers
Screen money managers from public funds and ETFs managed around the world
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Valuation
Check real value of public entities based on technical and fundamental data
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed Inc underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine ResMed value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.